Anonymized data from thousands of adults with long-term COVID-19 illness made available to researchers
what: Secure data from more than 14,000 adults participating in the National Institutes of Health observational study of the long-term novel coronavirus is now available to accredited researchers through BioData Catalyst (BDC). BDC is a cloud-based ecosystem developed by the National Heart, Lung, and Blood Institute (NHLBI), part of the NIH, to accelerate research into heart, lung, blood, and sleep disorders.Research on the long-term novel coronavirus — Broadly defined as signs, symptoms, or conditions that persist or develop for at least four weeks after infection with the virus that causes coronavirus disease (COVID-19) and are available through the NIH Researching COVID to Enhance Recovery (NIH RECOVER) Initiative will be done.
By providing researchers with access to secure data, analytical tools, and resources, the BDC ecosystem fosters scientific innovation, collaboration, and discovery while providing a platform to share data and validate results. We aim to do so. Adding RECOVER data to BDC will help researchers identify and investigate long-term coronavirus associations that may benefit or inform future research.
Authorized researchers can now request access to a subset of data from adults in the observed RECOVER cohort. These data include information from more than 92,000 study visits collected between October 29, 2021 and September 29, 2021. It will be held at 79 locations across the United States starting on the 15th of 2023. New HER RECOVER data, including data from other studies, will be added to HER BDC periodically.
As researchers aim to better understand, diagnose and treat long-lasting coronavirus infections, many important questions remain. By adding RECOVER data to a central ecosystem and making it more accessible, experts aim to find answers faster.
Who: David C. Goff, MD, Ph.D., Senior Scientific Program Director for the RECOVER Observational Consortium Steering Committee and Director of NHLBI's Division of Cardiovascular Sciences, is a new direction in BDC and long-term COVID-19 research. We can discuss sexuality.